Dosage of dexferroxamin 500 mg when ferritin is coming 3k in case of MDS??
Reading File
Finding Sources
Searching PubMed
deferoxamine iron chelation myelodysplastic syndrome
Searching the Web
deferoxamine 500mg dosage ferritin 3000 MDS myelodysplastic syndrome iron overload
Here is a clear, evidence-based answer on deferoxamine (Desferal) dosing in MDS with ferritin ~3,000 ng/mL:
Deferoxamine Dosing in MDS — Ferritin ~3,000 ng/mL
Why Iron Chelation in MDS?
Patients with MDS often receive repeated RBC transfusions, leading to secondary iron overload. Chelation is indicated when serum ferritin > 1,000–2,500 ng/mL (varies by guideline) in transfusion-dependent patients, especially those who are transplant-eligible.
Dosing by Ferritin Level (Official Prescribing Information — Novartis/Pfizer)
| Serum Ferritin | Deferoxamine Dose |
|---|---|
| < 2,000 ng/mL | ~25 mg/kg/day |
| 2,000–3,000 ng/mL | ~35 mg/kg/day |
| > 3,000 ng/mL | Up to 55 mg/kg/day |
General range: 20–60 mg/kg/day. Do not routinely exceed 50 mg/kg/day unless intensive chelation is needed in a patient who has completed growth.
Route & Schedule
| Route | Details |
|---|---|
| Subcutaneous infusion (preferred) | 35 mg/kg/day over 8–12 hours, 5–7 nights/week via portable infusion pump |
| IV infusion | Adults: 40–50 mg/kg/day over 8–12 hours, 5–7 days/week. Max: 60 mg/kg/day |
| IM injection | 500 mg; max 1,000 mg/day — least preferred, less efficient |
Practical Point on "500 mg Vial" Strength
Deferoxamine comes as a 500 mg lyophilized powder per vial. This is the vial size, not the dose. The actual dose must be calculated per kg:
- Example: 60 kg patient with ferritin 3,000 → 35 mg/kg × 60 kg = 2,100 mg/day SC (≈ 4.2 vials)
- Example: 50 kg patient → 35 × 50 = 1,750 mg/day
Safety Monitoring
- Ferritin < 1,000 ng/mL: Reduce dose — toxicity risk increases
- Monitor: ophthalmologic & audiologic exam annually (ocular/ototoxicity)
- Contraindicated in severe renal impairment
- Vitamin C (up to 200 mg/day) can be given as adjuvant to enhance iron mobilization — start only after deferoxamine is established
MDS-Specific Considerations
- Deferoxamine is one of three chelators approved (alongside deferasirox — preferred oral option, and deferiprone — second line)
- In MDS, decisions must be individualized based on transfusion burden, transplant eligibility, performance status, and organ function
- Deferasirox (oral, once daily) is often preferred over deferoxamine in MDS due to convenience; deferoxamine is chosen when renal/hepatic impairment precludes deferasirox
Bottom line for your patient: Ferritin of 3,000 ng/mL falls at the upper end of the 2,000–3,000 range, so the target dose is ~35 mg/kg/day SC over 8–12 hours. Calculate exact daily mg based on body weight, reconstitute the 500 mg vials accordingly, and schedule 5–7 days/week. Monitor ferritin monthly and adjust downward if it drops below 1,000.
deferasirox Dosage in this case ??
Searching the Web
deferasirox dosage ferritin 3000 MDS myelodysplastic syndrome iron overload prescribing information
Finding Sources
Deferasirox Dosing in MDS — Ferritin ~3,000 ng/mL
Available Formulations
| Brand | Form | Strengths |
|---|---|---|
| Exjade | Dispersible tablet (dissolve in water) | 125 mg, 250 mg, 500 mg |
| Jadenu | Film-coated tablet / granules (swallow whole) | 90 mg, 180 mg, 360 mg |
Jadenu (FCT) has a better GI side-effect profile and is taken with a light meal; Exjade is taken on an empty stomach.
Starting Dose — Based on Transfusion Burden
| Transfusion Rate | Exjade Starting Dose | Jadenu Equivalent |
|---|---|---|
| < 4 units/month (< 14 mL/kg/month) | 20 mg/kg/day | 14 mg/kg/day |
| > 4 units/month (> 14 mL/kg/month) — more common in MDS | 30 mg/kg/day | 21 mg/kg/day |
| Low transfusion burden | 10 mg/kg/day | 7 mg/kg/day |
With ferritin at 3,000 ng/mL, the patient likely has significant iron overload and is probably transfusion-dependent → start at 20–30 mg/kg/day.
Dose Adjustment
- Monitor serum ferritin monthly
- Adjust dose every 3–6 months in steps of 5–10 mg/kg/day based on ferritin trend
- Maximum dose: 40 mg/kg/day (Exjade) / 28 mg/kg/day (Jadenu)
- Stop or reduce if ferritin falls below 500 µg/L (risk of over-chelation)
Practical Example (70 kg patient, ferritin 3,000, transfusion-dependent)
- Exjade: 20–30 mg/kg × 70 kg = 1,400–2,100 mg/day once daily on empty stomach
- Jadenu: 14–21 mg/kg × 70 kg = 980–1,470 mg/day once daily with light meal
Round to nearest available tablet size.
When to Initiate Chelation in MDS
| MDS Risk | Chelation Trigger |
|---|---|
| Low / INT-1 (e.g., MDS-SLD, 5q–, MDS-RS) | Ferritin > 1,000–1,500 µg/L + transfusion-dependent |
| INT-2 / High-risk MDS | Consider if life expectancy > 2 years and ferritin > 1,500 µg/L or after ≥ 20 units RBC |
| Transplant candidates | Always chelate to reduce organ toxicity pre-transplant |
Safety Monitoring
| Parameter | Frequency |
|---|---|
| Serum creatinine & eGFR | Before start, then monthly |
| LFTs (ALT/AST) | Monthly for first year |
| Serum ferritin | Monthly |
| Urine protein | Monthly |
| Audiology & ophthalmology | Annually |
Contraindications: eGFR < 40 mL/min, hepatic impairment (Child-Pugh B/C), platelet count < 50 × 10⁹/L.
Bottom line: For your MDS patient with ferritin 3,000 ng/mL, start deferasirox at 20 mg/kg/day (Exjade) or 14 mg/kg/day (Jadenu) if receiving < 4 units/month, or 30 mg/kg/day / 21 mg/kg/day if heavily transfused. Adjust every 3 months based on ferritin trend. Stop when ferritin drops below 500 µg/L.
What does ex jade and jadenu means
Exjade and Jadenu are simply the two brand names for the same drug — deferasirox — made by Novartis. They are not different drugs; they differ only in formulation.
Exjade (older formulation)
- Form: Dispersible tablet — must be dissolved in water or juice and drunk as a suspension
- Taken: On an empty stomach, 30 minutes before food
- Strengths: 125 mg, 250 mg, 500 mg
- Drawback: Many patients find it inconvenient and it has more GI side effects (nausea, diarrhea) because the entire dose hits the stomach at once
Jadenu (newer formulation)
- Form: Film-coated tablet (swallowed whole) or granules sprinkled on food
- Taken: With a light meal (no empty stomach required)
- Strengths: 90 mg, 180 mg, 360 mg
- Advantage: Better tolerability, simpler to take, improved GI side-effect profile
- The dose is ~30% lower than Exjade mg-for-mg because of better bioavailability with food (e.g., Exjade 20 mg/kg ≈ Jadenu 14 mg/kg)
Simple Analogy
Think of it like paracetamol syrup vs. paracetamol tablet — same molecule, different delivery system. Jadenu was developed to improve patient compliance over Exjade.
In clinical practice today, Jadenu (film-coated tablet) is generally preferred over Exjade due to convenience and tolerability, especially in MDS patients who are often elderly.
This is a shared conversation. Sign in to Orris to start your own chat.